Only one in 20 therapies tested in animals reach approval for human use
An analysis of reviews of translational biomedical research reveals that just 5% of therapies tested in animals reach regulatory approval for human use. The study, an umbrella review, published June…
Advancing personalised, data-​driven medicine. ETH Zurich’ s new BSS teaching and research building
When ETH Zurich established a new department in 2007 – in Basel, no less – with the aim of bringing together researchers from three disciplines, the idea was considered daring.…
TG SALUTEDOMANI TV: VACCINE AND CANCERS, MICROPLASTICS, ELECTRONIC SKIN
ONE VACCINE, MANY CANCERS In a new study published in Blood Advances, researchers from the UChicago Pritzker School of Molecular Engineering’s Hubbell Lab created with a novel approach to develop…
Lower dose of mpox vaccine is safe and generates six-week antibody response equivalent to standard regimen
Colorized scanning electron micrograph of mpox virus particles (blue) on the surface of infected VERO E6 cells (pink). NIAID A dose-sparing intradermal mpox vaccination regimen was safe and generated an…
A vaccine to fight antibiotic resistance
Driven by the overuse of antimicrobials, pathogens are quickly building up resistances to once-successful treatments. It’s estimated that antimicrobial-resistant infections killed more than 1 million people worldwide in 2019, according…
Artificial intelligence detects heart defects in newborns
Many children announce their arrival in the delivery room with a piercing cry. As a newborn automatically takes its first breath, the lungs inflate, the blood vessels in the lungs…
Tg Salutedomani Tv: AI and Parkinson’s disease, exercises after heart event, Covid and asthma in children
AI SPEEDS UP DRUG DESIGN FOR PARKINSON’S BY TEN-FOLD Researchers have used artificial intelligence techniques to massively accelerate the search for Parkinson’s disease treatments. The researchers, from the University of…
Gene therapy is halting cancer. Can it work against brain tumors?
Grant of up to $11 million will fund a clinical trial at UCSF that uses a smarter new CAR-T guided by precision technology. A type of gene therapy called CAR-T…
AI speeds up drug design for Parkinson’s by ten-fold
Researchers have used artificial intelligence techniques to massively accelerate the search for Parkinson’s disease treatments. The researchers, from the University of Cambridge, designed and used an AI-based strategy to identify…
mRna, MD Anderson and CureVac enter strategic collaboration to develop novel cancer vaccines
The University of Texas MD Anderson Cancer Center and CureVac N.V. today announced a co-development and licensing agreement to develop novel mRNA-based cancer vaccines. The collaboration creates strong synergies between…